Nasus Pharma CEO and Director Brendan O’Grady files initial beneficial ownership statement
NSRX•Nasus Pharma files Form 3 for Brendan P. O’Grady
Nasus Pharma filed an SEC Form 3 for Brendan P. O’Grady, naming him chief executive officer and director.
